Target intelligence / Profile preview

POU class 5 homeobox 1 (POU5F1)

Target
POU5F1
Molecular classification
Transcription factor, POU homeodomain family
01

Overview

POU class 5 homeobox 1 (POU5F1), commonly known as Oct-4, is a transcription factor of the POU homeodomain family that is critically involved in maintaining pluripotency and self-renewal in embryonic stem cells[3][4][7]. It binds DNA at octamer motifs and regulates expression of key genes required for early embryonic development, stem cell identity, and cellular reprogramming[4][7]. Proper expression is highly regulated; overexpression or aberrant reactivation in adult tissues is associated with tumorigenesis, increased proliferation, cancer cell "stemness," and resistance to multiple chemotherapeutics[1][2][7]. Oct-4 is one of the canonical "Yamanaka factors" used to generate induced pluripotent stem cells (iPSCs) from adult somatic cells, emphasizing its central role in cell fate determination[7]. In cancers, high POU5F1 expression is linked to poor prognosis, metastasis, and drug resistance, making it both a biomarker and potential therapeutic target in oncology[2][7].

Other names
Oct-4OCT4Oct4Oct-3Oct3/4OTF3OTF-3OTF4OTF-4NF-A3MGC22487Octamer-binding transcription factor 4Octamer-binding protein 4POU domain, class 5, transcription factor 1POU domain transcription factor OCT4Octamer-binding protein 3Octamer-binding transcription factor 3POU5F1B
02

Mechanism of action

Inhibition of POU5F1 expression (e.g., ATRA suppresses function, blocking downstream EMT/cancer progression); Targeting pluripotency maintenance pathways

03

Biological functions

Maintenance of stem cell pluripotencyEmbryonic developmentRegulation of gene expressionSomatic cell reprogramming (induced pluripotent stem cell generation)Tumorigenesis (in context of aberrant expression)Epithelial-mesenchymal transition (EMT) promotion
04

Disease associations

Cancer (multiple types, including gastric, lung, liver, testicular germ cell tumors, embryonal carcinoma, sarcoma)Tumorigenesis (cancer stem cell function and drug resistance)Role in stem cell deficiency disorders (if ablated)Other (dysplastic growths in epithelial tissues)
05

Safety considerations

Risk of promoting tumorigenesis/tumor progression when reactivated in adult tissuesPotential for teratoma formation when used in cell therapy/reprogramming contextsChemotherapy resistance when upregulated in tumors
06

Interacting drugs

All-trans retinoic acid (ATRA)

1 more in the full profile.

07

Biomarkers

High POU5F1 expression (marker of pluripotent stem cells and cancer stem cells, associated with poor prognosis in several cancer types)Used as a diagnostic/prognostic marker for undifferentiated tumor phenotype and stemness

Beyond the preview

Go deeper on POU class 5 homeobox 1 (POU5F1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POU class 5 homeobox 1 (POU5F1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call